PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+30.09%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.25B
AUM Growth
+$1.25B
(+12%)
Cap. Flow
-$74.5M
Cap. Flow
% of AUM
-5.97%
Top 10 Holdings %
Top 10 Hldgs %
50.46%
Holding
196
New
50
Increased
30
Reduced
37
Closed
40
Top Buys
| 1 |
uniQure
QURE
|
$20.5M |
| 2 |
Travere Therapeutics
TVTX
|
$20.2M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$18.2M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$12.5M |
| 5 |
CEMP
Cempra, Inc.
CEMP
|
$11.2M |
Top Sells
| 1 |
PTC Therapeutics
PTCT
|
$34.8M |
| 2 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$28.5M |
| 3 |
Esperion Therapeutics
ESPR
|
$26.7M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$19.3M |
| 5 |
AGN
ALLERGAN INC
AGN
|
$17.6M |
Sector Composition
| 1 | Healthcare | 82.46% |
| 2 | Technology | 0.06% |
| 3 | Financials | 0.04% |
| 4 | Energy | 0.02% |
